Top Markets
Coin of the day
SymBio Pharmaceuticals Limited SymBio Pharmaceuticals Limited

SymBio Pharmaceuticals Limited

4582
Rank in Stocks #28751
SymBio Pharmaceuticals Limited engages in the and development, manufacturing... SymBio Pharmaceuticals Limited engages in the and development, manufacturing and sales of pharmaceuticals and other related operations in Japan and internationally. It offers SyB V-1901, an antiviral drug for post-transplant infections, blood cancers and solid tumors, and neurodegenerative diseases; SyB L-1701, an RTD liquid formulation; and SyB L-1702, an RI administration under the TREAKISYM name. The company was incorporated in 2005 and is based in Minato, Japan.
Share Price
$0.45018154
Market Cap
$24.81M
Change (1 day)
1.47%
Change (1 year)
-56.57%
Country
JP
Trade SymBio Pharmaceuticals Limited (4582)

Category

Operating Margin for SymBio Pharmaceuticals Limited (4582)
Operating Margin as of 2026 TTM: 0.00%
According to SymBio Pharmaceuticals Limited latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for SymBio Pharmaceuticals Limited from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
62.34% -
US
0.00% -
SE
0.00% -
FR
0.77% -
US
0.00% -
IT
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.